Atomic AI
RNA Drug Discovery
1 open roleRNA Drug DiscoverySouth San Francisco, United States30 employees$42M raisedEst. 2021
8VC
Greylock
Playground Global
Factory HQ
NotBoring
AME Cloud Ventures
About Atomic AI
- Atomic AI is an early-stage biotech company that fuses artificial intelligence and structural biology.
- They are transforming the rational design of molecules and medicines to unlock the next generation of RNA-targeted small molecule and RNA-based therapeutics.
Atomic AI is listed on Rocketlist with 1 active role. The company is categorized as RNA Drug Discovery in BioTech. Atomic AI is at Series A stage, with a B2B business model, headquartered in South San Francisco, United States. Atomic AI was founded in 2021 and has 30 employees. Atomic AI has raised $42M. Active roles are refreshed daily from public hiring sources.